14 Dec 2018

52 Wk Range: 0.142 - 0.21

Day's Range: 0.17 - 0.17

Last Volume: 80,000

Last Close: SGD 0.17

Current Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

14 Dec 2018

Metric	42C	S.Median
Beta	0.32	0.24
VaR	35.76	36.18
E.Shortfall	43.98	52.9
Liquidity	94.93K	25.31K

13 Dec 2018

PE: NA

Market Cap: 108M

Price Over Book: 5.783

Price Over Sales: 16.74

Return On Assets: -44.2%

Return On Equity: -59.1%

NAV Over Price: [Friends Only]

[Members Only]

Sign up for free to access most features of StocksCafe

[Members Only]

Sign up for free to access most features of StocksCafe

iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical, Chemical Analysis, and Nutraceutical. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products. The Chemical Analysis segment provides laboratory testing services. The Nutraceutical segment offers nutraceutical products. The company was founded by Lee Yip Hang on May 8, 2004 and is headquartered in Singapore.

CEO: Yip Hang Lee

Founded Year: 2004

Headquarters: Singapore

Shares Outstanding: 644.1M

Security Type: Stock

Sector: Health Technology

Industry: Biotechnology

Useful Links
Homepage